The software industry experienced 4.8% growth in 2013, and Microsoft remains the world’s top software company. (The software industry experienced 4.8% growth in 2013, and @Microsoft remains the world’s top software company.
Pharma, Biotechnology, Biobanks, Research & Quality Control Agenda on February 26th, 2014 in Budapest, Hungary.
Gretel Posadas's insight:
From February 25th until 27th 2014
FRANCELAB SCIENTIFIC CONFERENCE DAYS
at the French Institute of Budapest, Hungary
Fö utca 17 (metro : BATTHYANY tér)
Agenda on February 26th, 2014 :
9.10 Sylvette Tourmente: Attachée de coopération scientifique, technique et universitaire à l’Ambassade de France en Hongrie: French - Hungarian research collaboration opportunities.
9.35 Romain BRUDER - HORIBA JOBIN YVON: «FLIM and nanoparticle- enhanced fluorescence, powerful tools for #Biotech applications of lifetime fluorescence»
10.00 BICZÓK László: MTA TTK - Molekuláris Farmakológiai Intézet: «Interaction of alkaloid and #macrocyclic compound studied by fluorescence methods»
10.25 HORNOK Viktória, BENKŐ Mária, DÉKÁNY Imre: SZEGEDI TUDOMÁNYEGYETEM - Kolloidkémiai Tanszék: «Dynamic light scattering for the determination of particle size distribution and z-potential of nanoparticles. Special applications in the 2-20 nm range with Horiba SZ-100.»
10.50 - Coffee Break
11.05 Michel DEPONT - CRYO BIO SYSTEM: «High Security #Biobanking Solution»
11.30 #Gretel POSADAS - #BIOSAMPLING SYSTEMS: «BioSampling Systems combines speed and high capacity to improve the #storage quality of sample management in biobanks, hospitals and blood transfusion centers»
11.55 Claude SIGWALT - ACTINI: «Effluents treatment in Biosafety labs»
12.20 - Lunch break
13.00 Stephan MOREAU - SETARAM: «μSC a new tool for #Pharmaceuticals and Biotech applications»
13.25 GYURCSÁNYI Róbert - BME Szervetlen és Analitikai Kémia Tankszék: «SPR imaging for the characterization of synthetic receptors.»
13.50 Romain BRUDER - HORIBA JOBIN YVON: «#Raman #spectoscopy for biological and pharmaceutical samples – a review of specific tools»
14.15 Sylvain MOREL - ALPHA MOS: «How to measure the taste without human tongue? the use of E-Tongue in Pharma #applications»
Reconstructing the rise of life during the period of Earth's history when it first evolved is challenging. Earth's oldest sedimentary rocks are not only rare, but also almost always altered by hydrothermal and tectonic activity.
(Medical Xpress)—Could a drug commonly prescribed to prevent bone loss boost the power of #vaccines?
New research from Harvard Medical School shows that adding compounds known as bisphosphonates to both commercial and experimental vaccines enhances their effectiveness in mice, raising hopes they could help people mount a more robust #immune response.
The country faces an infectious disease catastrophe caused by drug-resistant microbes, which affect an estimated 2 million people annually and kill 23,000 of them, federal health officials said Monday.
A recipe detailing how to make extraordinary stem cells from ordinary cells—just by "stressing" them with acid—will "soon" be posted for all to try, says Riken. This could settle much controversy surrounding the cells...or spur more.
Munich, January 31, 2014 - Icon Genetics GmbH (ICON) successfully completed a Phase I clinical study on the safety and immunogenicity of personalized vaccines to treat patients with follicular non-Hodgkin's lymphoma. The vaccines, which consist of monoclonal antibodies derived from each patient's own tumor and serve as disease-specific markers, were administered to induce a tumor-specific immune reaction. The vaccines were manufactured in tobacco plants using magnICON® technology in the facility owned and operated by ICON in Halle, Germany. Results of the 27-patient study demonstrated the safety, tolerability and tumor-specific immunogenicity of the plant-made vaccines. #Cancer patients receiving ICON's vaccines did not exhibit the types of side effects that are typically associated with more traditional approaches for cancer treatment. Thus, these vaccines have the potential of offering patients improved quality of life throughout their therapeutic regimen. While not designed to assess efficacy, the study evaluated immune responses to vaccination. Of the patients evaluated at study completion, 73% were found to have mounted a tumor-specific immune response. The Phase I trial was sponsored by Bayer Innovation GmbH and conducted under US FDA IND at 3 clinical centers in the United States, with primary treatment at the University of Texas Southwestern Medical Center and Baylor Medical Center, both in Dallas, Texas, with local coordination and oversight provided by DAVA Oncology, LP.
Would you like to become a professional on #NEO SAMPLE MANAGEMENT automate?
BioSampling Systems would like to invite you to the exclusive #training about the innovative technology behind this fantastic liquid handling robot.
Join us in our training #sessions from March 6th, 2014 until May 30th 2014: 1st Training session: Monday March 17th, 2014 2nd Training session: Monday April 21st, 2014 3rd Training session: Monday May 19th, 2014
Yes, You would like to assist to NEO Training contact us at firstname.lastname@example.org Object : NEO SAMPLE MANAGEMENT TRAINING
Trophic cascade effects occur when a food web is disrupted by loss or significant reduction of one or more of its members. In East African Rift Valley lakes, the Lesser Flamingo is on top of a short food chain. At irregular intervals, the dominance of their most important food source, the cyanobacterium Arthrospira fusiformis, is interrupted. Bacteriophages are known as potentially controlling photoautotrophic bacterioplankton. In Lake Nakuru (Kenya), we found the highest abundance of suspended viruses ever recorded in a natural aquatic system. We document that cyanophage infection and the related breakdown of A. fusiformis biomass led to a dramatic reduction in flamingo abundance. This documents that virus infection at the very base of a food chain can affect, in a bottom-up cascade, the distribution of end consumers. We anticipate this as an important example for virus-mediated cascading effects, potentially occurring also in various other aquatic food webs.
BioSampling Systems and our French Vendor "DAY medical" are having a great time with our customers of 3S System and SSP Plate 48 at JIB 2013. Today is our last day come and visit our stand ! For more information about our liquind handling options visit : www.biosamplingsystems.com
3S 1mL is the new #system designed for our SSP 48 1mL plate. This new version of the 3S system alllows any #laboratory to store up to1mL of #liquid sample in our monoblock plate in a reliable and secure way. The 3S System guarantees the management of the complete life cycle of each #sample.
For more information visit us in Ilex South Africa Ldt stand at the #BloodBank #Congress from 1 until 3 Oct 2013 ! BioSampling Systems and our 3S System automate for 1mL would be there !
The New Indian Express Aid for renovation of biotechnology centre The New Indian Express Aimed at strengthening and modernising the centre, the government has sanctioned Rs 93.1 lakh for the modernisation of equipment, upgradation and strengthening...